Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.80
-0.55 (-1.87%)
Apr 20, 2026, 1:05 PM CST

TPE:1762 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
804.881,3472,0862,1171,935
Revenue Growth (YoY)
-40.26%-35.42%-1.45%9.43%25.34%
Cost of Revenue
813.74953.061,3291,155985.31
Gross Profit
-8.86394.32757.31961.76949.39
Selling, General & Admin
142.33182.14233.8271.78239.89
Research & Development
168.35205.84242.7244.79252.67
Operating Expenses
310.67387.98476.5498.23510.91
Operating Income
-319.546.34280.81463.53438.48
Interest Expense
-16.63-21.13-17.97-9.68-3.27
Interest & Investment Income
3.788.658.254.510.18
Earnings From Equity Investments
57.2544.8736.5151.150.1
Currency Exchange Gain (Loss)
-5.3723.646.8856.82-9.59
Other Non Operating Income (Expenses)
7.779.688.258.1318.45
EBT Excluding Unusual Items
-272.7372.04322.72574.41494.34
Gain (Loss) on Sale of Investments
16.92-15.4210.779.593.27
Gain (Loss) on Sale of Assets
-0.61--0.7-
Other Unusual Items
0.13----
Pretax Income
-255.6857.22333.49583.31497.61
Income Tax Expense
-11.834.1968.58117.1796.56
Earnings From Continuing Operations
-243.8553.03264.91466.14401.05
Minority Interest in Earnings
----0.28-0.27
Net Income
-243.8553.03264.91465.87400.78
Net Income to Common
-243.8553.03264.91465.87400.78
Net Income Growth
--79.98%-43.14%16.24%-24.65%
Shares Outstanding (Basic)
5656787878
Shares Outstanding (Diluted)
5656787978
Shares Change (YoY)
-1.27%-27.92%-0.52%0.23%-0.02%
EPS (Basic)
-4.390.953.426.015.17
EPS (Diluted)
-4.390.943.395.935.12
EPS Growth
--72.27%-42.83%15.82%-24.59%
Free Cash Flow
81.24364.57-516.27359.12-184.18
Free Cash Flow Per Share
1.466.48-6.614.58-2.35
Dividend Per Share
-0.1900.8001.3001.300
Dividend Growth
--76.25%-38.46%--13.33%
Gross Margin
-1.10%29.27%36.30%45.43%49.07%
Operating Margin
-39.70%0.47%13.46%21.89%22.66%
Profit Margin
-30.30%3.94%12.70%22.00%20.71%
Free Cash Flow Margin
10.09%27.06%-24.74%16.96%-9.52%
EBITDA
-128.19205.5473.81632.58570.47
EBITDA Margin
-15.93%15.25%22.71%29.88%29.49%
D&A For EBITDA
191.35199.16193.01169.05131.99
EBIT
-319.546.34280.81463.53438.48
EBIT Margin
-39.70%0.47%13.46%21.89%22.66%
Effective Tax Rate
-7.32%20.56%20.09%19.41%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.